US investor Alfred Mann said Monday he will invest some $250 million to construct a factory that will produce insulin inhalers developed by a subsidiary of medical equipment giant MannKind Corp. The factory is slated to be built in either the Gush Segev industrial park or in Netanya.
Construction of the factory will take two to three years, and it will employ several hundred workers when completed, a figure Mann intends to increase to several thousand.
MannKind's insulin inhaler is undergoing final trials for US Food & Drug Administration (FDA) approval.
Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>